Consultation on Lymantria dispar multicapsid nucleopolyhedrovirus strain LDP-67 and BoVir, Proposed Registration Decision PRD2024-05

Health Canada's Pest Management Regulatory Agency (PMRA), under the authority of the Pest Control Products Act, is proposing registration for the sale and use of Disparvirus Technical and BoVir, containing the active ingredient Lymantria dispar multicapsid nucleopolyhedrovirus (LdMNPV) strain LDP-67, to suppress spongy moth (Lymantria dispar) in residential areas.

How to get involved

This consultation is open for comment from 29 April 2024 to 13 June 2024 (45 calendar days). Open the "Consultation Summary" to access the document.

If you would like to comment, see the Pest Management Regulatory Agency Publications Section page for contact information. Please be sure to include the title of the consultation document on which you are commenting.

Health Canada will consider all comments received up to 45 days from the date of publication of this document (by 13 June 2024) before making a final decision on the proposed registration for Lymantria dispar multicapsid nucleopolyhedrovirus strain LDP-67 and BoVir.

Reporting to Canadians

Health Canada will make the results of this consultation available on this website. Once the decision on Lymantria dispar multicapsid nucleopolyhedrovirus strain LDP-67 and BoVir is finalized, the PMRA will post a Registration Decision on the Pesticides and Pest Management Reports and Publications portion of Canada.ca.

If you have any questions, contact the Pest Management Information Service.

Interested in our other consultations? Sign up and stay informed about topics that matter to you.